during the course of a prospective , randomised trial comparing dextran 40 with antithrombin iii plus heparin as prophylaxis against thrombosis after total hip replacement , an unexpectedly low incidence of postoperative thromboembolic disease was found in patients receiving non-cemented ( 0 of 23 ) rather than cemented prostheses ( 4 of 13 , 31 % ) .
C0011793
dextran 40
C0040038
thromboembolic